Cargando…

Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency

Background: medication-assisted treatment (MAT) with buprenorphine is now widely prescribed to treat addiction to heroin and other illicit opioids. There is some evidence that illicit opioids enhance HIV-1 replication and accelerate AIDS pathogenesis, but the effect of buprenorphine is unknown. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gornalusse, Germán Gustavo, Vojtech, Lucia N., Levy, Claire N., Hughes, Sean M., Kim, Yeseul, Valdez, Rogelio, Pandey, Urvashi, Ochsenbauer, Christina, Astronomo, Rena, McElrath, Julie, Hladik, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402857/ https://www.ncbi.nlm.nih.gov/pubmed/34452338 http://dx.doi.org/10.3390/v13081472

Ejemplares similares

Innate immune regulation in HIV latency models
por: Olson, Rebecca M., et al.
Publicado: (2022)

Potent Restriction of Sexual Zika Virus Infection by the Lipid Fraction of Extracellular Vesicles in Semen
por: Wang, Ruofan, et al.
Publicado: (2020)

Corrigendum: Potent Restriction of Sexual Zika Virus Infection by the Lipid Fraction of Extracellular Vesicles in Semen
por: Wang, Ruofan, et al.
Publicado: (2021)

Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure
por: Bender Ignacio, Rachel A., et al.
Publicado: (2022)

Men who inject opioids exhibit altered tRNA-Gly-GCC isoforms in semen
por: Gornalusse, Germán, et al.
Publicado: (2023)

Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune Activation
por: Kosmider, Ewelina, et al.
Publicado: (2023)

Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4(+) T cell activation and HIV-1 latency reversal
por: Cao, Shijie, et al.
Publicado: (2019)

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection
por: Astronomo, Rena D., et al.
Publicado: (2016)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Latency: the hidden HIV-1 challenge
por: Marcello, Alessandro
Publicado: (2006)

Molecular Understanding of HIV-1 Latency
por: Abbas, W., et al.
Publicado: (2012)

HIV-1 latency in activated T-cells
por: Berkhout, Ben
Publicado: (2013)

HIV-1 Latency in Monocytes/Macrophages
por: Kumar, Amit, et al.
Publicado: (2014)

HIV-1 transcription and latency: an update
por: Van Lint, Carine, et al.
Publicado: (2013)

COVID-19 vaccination and HIV-1 acquisition – Authors’ reply
por: Buchbinder, Susan P, et al.
Publicado: (2022)

Epigenetic Heterogeneity in HIV-1 Latency Establishment
por: Matsuda, Yuka, et al.
Publicado: (2015)

HIV-1 Induces Cytotoxic T Lymphocytes in the Cervix of Infected Women
por: Musey, Luwy, et al.
Publicado: (1997)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection
por: Liu, Yi, et al.
Publicado: (2011)

Bioinformatics and HIV Latency
por: Ciuffi, Angela, et al.
Publicado: (2015)

HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities
por: Seaton, Kelly E., et al.
Publicado: (2014)

Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency
por: Jean, Maxime Junior, et al.
Publicado: (2017)

Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

Cell free HIV-1 virus can infect inner and outer foreskin polarized explants
por: Lemos, MP, et al.
Publicado: (2012)

Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
por: Kauder, Steven E., et al.
Publicado: (2009)

Impact of the Ku Complex on HIV-1 Expression and Latency
por: Manic, Gwenola, et al.
Publicado: (2013)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
por: Søgaard, Ole S., et al.
Publicado: (2015)

HIV-1 Proviral Transcription and Latency in the New Era
por: Shukla, Ashutosh, et al.
Publicado: (2020)

Hypoxic microenvironment shapes HIV-1 replication and latency
por: Zhuang, Xiaodong, et al.
Publicado: (2020)

Mathematical Models of HIV-1 Dynamics, Transcription, and Latency
por: D’Orso, Iván, et al.
Publicado: (2023)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
por: Khanal, Sushant, et al.
Publicado: (2021)

The BAF complex and HIV latency
por: Mahmoudi, Tokameh
Publicado: (2012)

A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency
por: Garliss, Caroline C, et al.
Publicado: (2020)

HIV-1 latency in actively dividing human T cell lines
por: Jeeninga, Rienk E, et al.
Publicado: (2008)

Valproic acid and HIV-1 latency: beyond the sound bite
por: Smith, Stephen M
Publicado: (2005)

Centrosomal pre-integration latency of HIV-1 in quiescent cells
por: Zamborlini, Alessia, et al.
Publicado: (2007)

Differential proviral latency of the HIV-1 subtypes B and AE
por: van der Sluis, Renée M, et al.
Publicado: (2011)

Gene silencing in HIV-1 latency by polycomb repressive group
por: Kim, Hyeon Guk, et al.
Publicado: (2011)

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
por: Donahue, Daniel A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hadne5a71jv1cflpveimlab595